Authors
Fish, Leslie S.UMass Chan Affiliations
Meyers Primary Care InstituteDocument Type
Journal ArticlePublication Date
2006-04-15Keywords
Biological AgentsCost Sharing
Cost-Benefit Analysis
Drug Costs
Humans
Managed Care Programs
Patient Participation
United States
Health Services Research
Pharmacy and Pharmaceutical Sciences
Primary Care
Metadata
Show full item recordAbstract
Although there were few users of biologics in the past, today many more common conditions, such as rheumatoid arthritis, asthma, and hepatitis C, are being treated with biologics. Payers must be able to determine the true cost benefit of a therapy and provide this information to patients.Source
Am J Manag Care. 2006 Apr;12(6 Suppl):S159-61; discussion S167-72; quiz S173-6.